InnovaQor, Inc. confirms trading symbol change to INQR

WEST PALM BEACH, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), confirms a new trading symbol, INQR, for its common shares will be effective on February 14, 2023

InnovaQor is pleased to confirm that FINRA has today confirmed the name change from VisualMED Clinical Solutions Corporation to InnovaQor, Inc., and the change of its trading symbol for its common stock from VMCS to INQR on OTC Markets, will be effective on February 14, 2023. The Companys’ common shares will trade under the symbol INQR on OTC Markets at the open of markets on February 14, 2023. There is no change to the cusip number representing the Companys’ common shares.

“We are pleased to have these final transition changes completed” said Sharon Hollis, CEO of InnovaQor, Inc. “We can now focus on creating a strong brand and trading history, for our new business and strategy”

For further information on InnovaQor, Inc., please visit 

About InnovaQor, Inc.

InnovaQor delivers innovative technology and software solutions for the medical sector and intends to build a communication platform specifically for the medical sector, which will facilitate communication and collaboration between peers and allow the addition of revenue generating bolt on offers, including existing solutions and a new recruitment matching product for the healthcare sector.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these, and other risk factors, is contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. 

Contact: 

Gerard Dab 

561 421 1905